市場調査レポート
商品コード
975756

先進ドラッグデリバリーシステム (DDS):市場・技術の分析

Global Markets and Technologies for Advanced Drug Delivery Systems

出版日: | 発行: BCC Research | ページ情報: 英文 243 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
先進ドラッグデリバリーシステム (DDS):市場・技術の分析
出版日: 2020年12月09日
発行: BCC Research
ページ情報: 英文 243 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の先進ドラッグデリバリーシステム (DDS) の市場規模は予測期間中6.1%のCAGRで推移し、2020年の2310億米ドルから、2025年には3100億米ドルの規模に成長すると予測されています。地域別では、北米地域が5.8%のCAGRで推移し、2020年の1040億米ドルから、2025年には1380億米ドルの規模に成長する見通しです。また、アジア太平洋地域は6.7%のCAGRで推移し、347億米ドルから、480億米ドルの規模に成長する見通しです。

当レポートでは、世界の先進ドラッグデリバリーシステム (DDS) の市場を調査し、市場の定義と概要、市場規模の推移・予測、技術・投与経路・担体・用途・地域など各種区分別の内訳、市場成長への各種影響因子の分析、特許動向、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場分析・予測:技術別

  • 先進DSSの技術:概要
  • 即時リリース
  • 修飾ドラッグデリバリー
  • サマリー

第4章 市場分析・予測:投与経路別

  • 先進DDSの投与経路:概要
  • 経口
  • 非経口/注射用
  • 局所
  • 経皮
  • 経粘膜
  • 経鼻・肺
  • 経眼
  • 経口:頬側
  • 経膣
  • 経直腸
  • 経粘膜
  • インプラント
  • 避妊用ドラッグデリバリーデバイス
  • サマリー

第5章 市場分析・予測:担体別

  • 先進DDSの担体:概要
  • リポソーム
  • 高分子治療薬
  • 高分子ミセル
  • デンドリマー
  • 高分子
  • ナノキャリア/ナノ粒子
  • 微粒子/ミクロスフェア
  • モノクローナル抗体(MAb)
  • プロドラッグ
  • その他
  • サマリー

第6章 市場分析・予測:用途別

  • 先進DDSの用途:概要
  • 心臓血管
  • 腫瘍
  • 胃腸障害
  • 泌尿器
  • 糖尿病
  • 皮膚
  • 中枢神経
  • 呼吸器
  • 炎症性疾患・アレルギー
  • 眼科
  • ウイルス性・細菌性疾患
  • ホルモン補充療法・婦人科
  • その他
  • サマリー

第7章 市場分析・予測:地域別

  • 先進DDSの地域的分布:概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域
  • サマリー

第8章 先進医療機器産業の概要

  • M&A
  • 臨床試験の動向

第9章 特許レビュー

第10章 市場概要

  • 市場概要
  • 市場成長推進因子・阻害因子
  • 市場推計・分析

第11章 企業プロファイル

  • ABBOTT LABORATORIES
  • ADARE PHARMACEUTICALS
  • ALCON INC.
  • ALKERMES
  • AMGEN INC.
  • ASTRAZENECA PLC
  • BAUSCH & LOMB
  • BAXTER INTERNATIONAL INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BIOGEN IDEC
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRISTOL-MYERS SQUIBB
  • CAPSUGEL (LONZA)
  • CATALENT
  • CURE PHARMACEUTICAL
  • EISAI CO., LTD.
  • ENZON PHARMACEUTICALS
  • GENENTECH INC (ROCHE)
  • GENEREX BIOTECHNOLOGY CORP.
  • GILEAD SCIENCES INC.
  • GLAXOSMITHKLINE PLC
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • ELI LILLY AND CO.
  • JANSSEN BIOTECH INC.
  • JOHNSON & JOHNSON
  • KEMPHARM INC.
  • MANNKIND CORP.
  • MERCK & CO.
  • MYLAN LABORATORIES INC.
  • NEKTAR THERAPEUTICS
  • NOVARTIS AG
  • NOVAVAX INC.
  • NOVEN PHARMACEUTICALS
  • PFIZER INC.
  • ROCHE HOLDING AG
  • SANOFI SA
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • XEL PHARMACEUTICALS
図表

List of Tables

  • Summary Table : Global Market for Advanced Drug Delivery Systems, by Region, Through 2025
  • Table 1 : Main Orally Disintegrating Drug Delivery Technologies
  • Table 2 : Comparison of Different Orally Disintegrating Drug Delivery Technologies
  • Table 3 : Examples of Drugs Using Orally Disintegrating Drug Delivery Technologies
  • Table 4 : Examples of Average Annual Revenues for Companies That Have Developed Advanced Oral Drug Delivery Technology
  • Table 5 : Global Market for Advanced Immediate-Release Systems, Through 2025
  • Table 6 : Global Market Shares of Advanced Modified Drug Release Systems, by Type, 2020
  • Table 7 : Examples of Delivery Carriers for Targeted Drug Delivery Systems
  • Table 8 : Examples of FDA-approved ADC Drugs
  • Table 9 : Global Market for Advanced Antibody Drug Conjugates, Through 2021
  • Table 10 : Global Market Shares of Advanced Targeted Drug Release Systems, by Type, 2020
  • Table 11 : Examples of Current U.S. FDA-Approved Nanoparticles and Type of Targeting Employed, Indications, Advantages and Drawbacks
  • Table 12 : Examples of Companies Developing Targeted Drug Delivery Systems
  • Table 13 : Global Market Shares of Advanced Targeted Drug Release Systems, by Route of Administration, 2020
  • Table 14 : Global Market for Advanced Targeted Release Drug Delivery Systems, Through 2025
  • Table 15 : Global Market Shares of Advanced Extended Drug Release Systems, by Route of Administration, 2020
  • Table 16 : Global Market Shares of Advanced Extended Controlled Drug Release Systems vs Extended Sustained Drug Release, by Type, 2020
  • Table 17 : Classic Methods of Extended-Release Delivery Systems and Their Limitations
  • Table 18 : Global Market Shares of Advanced Extended Drug Release Systems, by Drug Delivery Vehicle, 2020
  • Table 19 : Examples of Companies Developing and Offering Extended Drug Delivery Systems
  • Table 20 : Examples of Average Annual Revenues for Companies that Developed Extended Drug Release Technology
  • Table 21 : Global Market for Advanced Extended Release Drug Delivery Devices, Through 2025
  • Table 22 : Examples of Diseases that Require Pulsatile Drug Delivery Systems
  • Table 23 : Examples of FDA-Approved Advanced Pulsatile Drug Delivery Systems
  • Table 24 : Examples of Pulsatile Drug Delivery Systems on the Market and the Market Players That Developed Them
  • Table 25 : Global Market for Advanced Delayed Release and Pulsatile Release Drug Delivery Systems, Through 2025
  • Table 26 : Global Market for Advanced Drug Delivery Systems, by Release Technology, Through 2025
  • Table 27 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2020
  • Table 28 : Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2020
  • Table 29 : Advantages and Disadvantages of Different Routes of Drug Administration
  • Table 30 : Examples of Oral Fast Dissolved/Disintegrated Technologies and Related Products
  • Table 31 : Examples of Average Annual Revenues for Companies that Develop Oral Route Administration Technology
  • Table 32 : Global Market for Advanced Oral Drug Delivery Systems, Through 2025
  • Table 33 : Examples of Specialized Parenteral Routes of Administration
  • Table 34 : Global Market for Advanced Parenteral Advanced Drug Delivery Systems, Through 2025
  • Table 35 : Types of Topical Medications
  • Table 36 : Examples of Topical Medications on the Market
  • Table 37 : Global Market for Advanced Topical Drug Delivery Systems, Through 2025
  • Table 38 : Examples of Transdermal Medications on the Market
  • Table 39 : Examples of Average Annual Revenues for Companies that Develop Transdermal Route Administration Technology
  • Table 40 : Global Market for Advanced Transdermal Drug Delivery Systems, Through 2025
  • Table 41 : Transmucosal Drug Delivery
  • Table 42 : Global Market for Advanced Transmucosal Nasal and Pulmonary Drug Delivery Systems, Through 2025
  • Table 43 : Examples of Hydrogels and Composites Developed for Ocular Drug Delivery
  • Table 44 : Global Market for Advanced Ocular Advanced Drug Delivery Systems, Through 2025
  • Table 45 : Examples of Marketed Medications Delivered by the Oral-Buccal Route of Administration
  • Table 46 : Global Market for Advanced Oral Buccal Drug Delivery Systems, Through 2025
  • Table 47 : Global Market for Advanced Vaginal Drug Delivery Systems, Through 2025
  • Table 48 : Examples of Rectal Formulations Clinically Approved
  • Table 49 : Global Market for Advanced Rectal Advanced Drug Delivery Systems, Through 2025
  • Table 50 : Global Market for Advanced Transmucosal Drug Delivery Systems, by Route of Administration, Through 2025
  • Table 51 : Global Market Shares of Different Transmucosal Drug Delivery Routes
  • Table 52 : Examples of Implantable Drug Devices on the Market
  • Table 53 : Global Market for Advanced Implant Drug Delivery Systems, Through 2025
  • Table 54 : Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2025
  • Table 55 : Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2020
  • Table 56 : Examples of Clinically Approved Liposome-Based Therapeutics on the Market
  • Table 57 : Global Market for Liposomes for Advanced Drug Delivery Devices, Through 2025
  • Table 58 : Examples of Stimuli-Responsive Polymeric Micelles for Cancer Therapy in Research and Development
  • Table 59 : Global Market for Polymeric Micelles for Advanced Drug Delivery Devices, Through 2025
  • Table 60 : Examples of Dendrimer-Drug Interactions in Cancer Therapy in Research and Development
  • Table 61 : Global Market for Dendrimers for Advanced Drug Delivery Devices, Through 2025
  • Table 62 : Examples of Polymer Drugs in Late Stage Development or Commercially Available
  • Table 63 : Global Market for Polymeric Drugs for Advanced Drug Delivery Devices, Through 2025
  • Table 64 : Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drug, 2020
  • Table 65 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, Through 2025
  • Table 66 : Examples of Nanocarriers in Drug Delivery and their Characteristics
  • Table 67 : Shares of Different Types of Nanoparticles Used for Drug Delivery in Approved Drugs
  • Table 68 : Examples of FDA-Approved Nanodrugs Available for Clinical Use
  • Table 69 : Global Market for Nanocarriers/Nanoparticles for Advanced Drug Delivery Devices, Through 2025
  • Table 70 : Comparison of Control Release Devices
  • Table 71 : Global Market for Microparticles/Microspheres for Advanced Drug Delivery Devices, Through 2025
  • Table 72 : Examples of FDA-Approved Monoclonal Antibodies on the Market
  • Table 73 : Global Market for Monoclonal Antibodies for Advanced Drug Delivery Devices, Through 2025
  • Table 74 : Examples FDA-Approved Prodrugs on the Market
  • Table 75 : Global Market for Prodrugs for Advanced Drug Delivery Devices, Through 2025
  • Table 76 : Global Market for Other Drug Delivery Vehicles/Carriers for Advanced Drug Delivery Devices, Through 2025
  • Table 77 : Global Market for Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, Through 2025
  • Table 78 : Global Market Shares of Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, 2020
  • Table 79 : Ten Leading Cause of Death Worldwide in 2015
  • Table 80 : Examples of Different Systems Used in the Cardiovascular Delivery of Therapeutics
  • Table 81 : Global Market for Advanced Drug Delivery Systems in Cardiovascular Applications, Through 2025
  • Table 82 : Examples of Clinically Approved Cancer Nanomedicines
  • Table 83 : Global Market for Advanced Drug Delivery Systems in Oncology Applications, Through 2025
  • Table 84 : Examples of Gastroretentive Products Available on the Market
  • Table 85 : Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorder Applications, Through 2025
  • Table 86 : Global Market for Advanced Drug Delivery Systems in Urology Applications, Through 2025
  • Table 87 : Examples of Drug Delivery Systems for Diabetes Treatment
  • Table 88 : Global Market for Advanced Drug Delivery Systems in Diabetes Applications, Through 2025
  • Table 89 : Global Market for Advanced Drug Delivery Systems in Dermatology Applications, Through 2025
  • Table 90 : Examples of Marketed Nanopharmaceuticals for Brain Disorders
  • Table 91 : Global Market for Advanced Drug Delivery Systems in Central Nervous System Applications, Through 2025
  • Table 92 : Global Market for Advanced Drug Delivery Systems in Respiratory Applications, Through 2025
  • Table 93 : Examples of Nanoparticle-Based Medicines in Clinical Trials
  • Table 94 : Global Market for Advanced Drug Delivery Systems in Inflammatory and Allergy Applications, Through 2025
  • Table 95 : Examples of Ophthalmology Drug Delivery Systems in R&D
  • Table 96 : Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, Through 2025
  • Table 97 : Examples of Approved Nanoplatforms for Drug Delivery, by the FDA, EMA and Other Organizations
  • Table 98 : Examples of Antibacterial Drug Delivery Systems in R&D
  • Table 99 : Global Market for Advanced Drug Delivery Systems in Viral and Bacterial Disease Applications, Through 2025
  • Table 100 : Global Market for Advanced Drug Delivery Systems in Hormone Replacement Therapy and Gynecological Applications, Through 2025
  • Table 101 : Global Market for Advanced Drug Delivery Systems in Other Therapeutic Applications, Through 2025
  • Table 102 : Global Market for Advanced Drug Delivery Systems, by Application, Through 2025
  • Table 103 : Global Market Shares of Advanced Drug Delivery Systems, by Application, 2020
  • Table 104 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2020
  • Table 105 : Global Market for Advanced Drug Delivery Systems, by Region, Through 2025
  • Table 106 : Distribution of Types of Drug Delivery Systems Involved in M&A Deals
  • Table 107 : Clinical Trials Related to Drug Release Mechanisms
  • Table 108 : Clinical Trials Related to the Route of Administration of the Drug
  • Table 109 : Clinical Trials Related to Drug Carriers
  • Table 110 : Patents and Patent Applications Worldwide on Drug Delivery Release Mechanisms
  • Table 111 : Examples of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms
  • Table 112 : Patents and Patent Applications Worldwide on Drug Delivery and Route of Administration Technologies
  • Table 113 : Examples of Patents and Patent Applications Filed on Drug Delivery and Route of Administration Technologies
  • Table 114 : Patents and Patent Applications Worldwide on Drug Delivery Applications
  • Table 115 : Examples of Patents and Patent Applications Filed on Drug Delivery Applications
  • Table 116 : Search Analysis for Patents and Patent Applications Worldwide Using Keyword Combinations on Drug Delivery Carriers
  • Table 117 : Examples of Patents and Patent Applications Filed on Drug Delivery Carriers
  • Table 118 : Number of Patents and Patent Applications, by Company
  • Table 119 : Examples of Patents and Patent Applications Filed on Drug Delivery, by Different Companies
  • Table 120 : Global Market for Advanced Drug Delivery Systems, Through 2025
  • Table 121 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2020
  • Table 122 : Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2020
  • Table 123 : Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2020

List of Figures

  • Summary Figure : Global Market for Advanced Drug Delivery Systems, by Region, 2018-2025
  • Figure 1 : Global Market for Advanced Drug Delivery Systems, by Drug Release Mechanism
  • Figure 2 : Global Market for Advanced Immediate-Release Systems, 2018-2025
  • Figure 3 : Global Market Shares of Advanced Modified Drug Release Systems, by Type, 2020
  • Figure 4 : Global Market for Advanced Targeted Release Drug Delivery Systems, 2018-2025
  • Figure 5 : Global Market for Advanced Extended Release Drug Delivery Devices, 2018-2025
  • Figure 6 : Global Market for Advanced Delayed Release and Pulsatile Release Drug Delivery Systems, 2018-2025
  • Figure 7 : Global Market for Advanced Drug Delivery Systems, by Release Technology, 2018-2025
  • Figure 8 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2020
  • Figure 9 : Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2020
  • Figure 10 : Global Market for Advanced Oral Drug Delivery Systems, 2018-2025
  • Figure 11 : Global Market for Advanced Parenteral Drug Delivery Systems, 2018-2025
  • Figure 12 : Global Market for Advanced Topical Drug Delivery Systems, 2018-2025
  • Figure 13 : Global Transdermal Advanced Drug Delivery Systems, 2018-2025
  • Figure 14 : Global Market for Advanced Transmucosal Drug Delivery Systems, by Route of Administration, 2018-2025
  • Figure 15 : Global Market Shares of Different Transmucosal Drug Delivery Routes
  • Figure 16 : Global Market for Advanced Implant Drug Delivery Systems, 2018-2025
  • Figure 17 : Global Market for Advanced Drug Delivery Systems, by Route of Administration, 2018-2025
  • Figure 18 : Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2020
  • Figure 19 : Global Market for Liposomes for Advanced Drug Delivery Devices, 2018-2025
  • Figure 20 : Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drugs, 2020
  • Figure 21 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, 2018-2025
  • Figure 22 : Shares of Different Types of Nanoparticles Used for Drug Delivery in Approved Drugs
  • Figure 23 : Global Market for Nanocarriers/Nanoparticles for Advanced Drug Delivery Devices, 2018-2025
  • Figure 24 : Global Market for Microparticles/Microspheres for Advanced Drug Delivery Devices, 2018-2025
  • Figure 25 : Global Market for Monoclonal Antibodies for Advanced Drug Delivery Devices, 2018-2025
  • Figure 26 : Global Market for Prodrugs for Advanced Drug Delivery Devices, 2018-2025
  • Figure 27 : Global Market for Other Drug Delivery Vehicles/Carriers for Advanced Drug Delivery Devices, 2018-2025
  • Figure 28 : Global Market for Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, 2018-2025
  • Figure 29 : Global Market Shares of Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, 2020
  • Figure 30 : Global Market for Advanced Drug Delivery Systems in Cardiovascular Applications, 2018-2025
  • Figure 31 : Global Market for Advanced Drug Delivery Systems in Oncology Applications, 2018-2025
  • Figure 32 : Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorder Applications, 2018-2025
  • Figure 33 : Global Market for Advanced Drug Delivery Systems in Urology Applications, 2018-2025
  • Figure 34 : Global Market for Advanced Drug Delivery Systems in Diabetes Applications, 2018-2025
  • Figure 35 : Global Market for Advanced Drug Delivery Systems in Dermatology Applications, 2018-2025
  • Figure 36 : Global Market for Advanced Drug Delivery Systems in Central Nervous System Applications, 2018-2025
  • Figure 37 : Global Market for Advanced Drug Delivery Systems in Respiratory Applications, 2018-2025
  • Figure 38 : Global Market for Advanced Drug Delivery Systems in Inflammatory and Allergy Applications, 2018-2025
  • Figure 39 : Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, 2018-2025
  • Figure 40 : Global Market for Advanced Drug Delivery Systems in Viral and Bacterial Disease Applications, 2018-2025
  • Figure 41 : Global Market for Advanced Drug Delivery Systems in Hormone Replacement Therapy and Gynecological Applications, 2018-2025
  • Figure 42 : Global Market for Advanced Drug Delivery Systems in Other Therapeutic Applications, 2018-2025
  • Figure 43 : Global Market for Advanced Drug Delivery Systems, by Application, 2018-2025
  • Figure 44 : Global Market Shares of Advanced Drug Delivery Systems, by Application, 2020
  • Figure 45 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2020
  • Figure 46 : Global Market for Advanced Drug Delivery Systems, by Region, 2018-2025
  • Figure 47 : Distribution of Types of Drug Delivery Systems Involved in M&A Deals
  • Figure 48 : Global Market for Advanced Drug Delivery Systems, 2018-2025
  • Figure 49 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2020
  • Figure 50 : Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2020
  • Figure 51 : Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2020
目次
Product Code: PHM006L

Highlights:

The global market for advanced drug delivery systems should grow from $231.0 billion in 2020 to $310.0 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025.

North American market should grow from $104.0 billion in 2020 to $138.0 billion by 2025 at a CAGR of 5.8% through 2025.

Asia-Pacific market should grow from $34.7 million in 2020 to $48.0 billion by 2025 at a CAGR of 6.7% through 2025.

Report Scope:

This report represents a current and important business tool to evaluate technologies, trends, products and market participants in the advanced drug delivery sector. The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different types of industries.

Report Includes:

  • 62 data tables 62 additional tables
  • An overview of the global markets and technologies for advanced drug delivery systems
  • Analyses of global market trends, with data from 2018, 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • A look into the current state, setbacks, innovations, and future trends, and coverage of clinical trials in drug delivery systems
  • Discussion on the different categories of drug delivery, and details of acquisitions, mergers, and alliances by companies and global organizations
  • Description of advanced immediate-release technology and delayed release and pulsatile release drug delivery technology
  • Information on monoclonal antibodies (MAbs), Prodrugs and other drug carriers of advanced drug delivery systems
  • Insights of the regulatory environment, and the technology involved, including the latest trends and developments
  • Company profiles of major players including Alcon, Bausch & Lomb, Baxter International Inc., Eisai Co. Ltd., GlaxoSmithKline PLC, Eli Lilly, Novartis and Sanofi

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Evaluation of the Market Based on Technology

  • Overview of Advanced Drug Delivery Systems and Technologies
  • Immediate-release Segment
  • Modified Drug Delivery Segment
  • Summary of the Market for Advanced Drug Delivery Systems Based on Drug Release Mechanism

Chapter 4 Evaluation of the Market Based on Route of Administration

  • Overview of Advanced Drug Delivery Systems and Route of Administration
  • Oral Drug Delivery System Segment
  • Parenteral/Injectable Drug Delivery System Segment
  • Topical Drug Delivery System Segment
  • Transdermal Drug Delivery System Segment
  • Transmucosal Drug Delivery System Segment
  • Nasal and Pulmonary Drug Delivery System Segment
  • Ocular Drug Delivery System Segment
  • Oral-Buccal Drug Delivery Segment
  • Vaginal Drug Delivery Segment
  • Rectal Drug Delivery Segment
  • Transmucosal Drug Delivery System Segment
  • Implant Drug Delivery System Segment
  • Contraceptive Drug Delivery Device Segment
  • Summary of the Market for Advanced Drug Delivery Systems Based on Route of Administration

Chapter 5 Evaluation of the Market Based on Vehicle/Carrier

  • Overview of Advanced Drug Delivery Systems and Vehicles/Carriers
  • Liposomes as Drug Delivery Vehicles
  • Polymeric Therapeutics in Drug Delivery
  • Polymeric Micelles (Micelles) in Drug Delivery
  • Dendrimers in Drug Delivery
  • Polymers (Polymeric) in Drug Delivery
  • Nanocarriers/Nanoparticles in Drug Delivery
  • Microparticles/Microspheres in Drug Delivery
  • Monoclonal Antibodies (MAbs)
  • Prodrugs
  • Other Drug Carriers
  • Summary of the Market for Advanced Drug Delivery Systems Based on Drug Delivery Vehicle/Carrier

Chapter 6 Evaluation of the Market Based on Application

  • Overview of Advanced Drug Delivery Systems and Applications
  • Applications
  • Cardiovascular
  • Oncology
  • Gastrointestinal (GI) Disorders
  • Urology
  • Diabetes
  • Dermatology
  • Central Nervous System
  • Respiratory
  • Inflammatory Diseases and Allergies
  • Ophthalmology
  • Viral and Bacterial Diseases
  • Hormone Replacement Therapy and Gynecology
  • Other Therapeutic Applications
  • Summary of the Market for Advanced Drug Delivery Systems Based on Application

Chapter 7 Evaluation of the Market Based on Geographic Region

  • Overview of the Geographical Distribution of the Market for Advanced Drug Delivery Systems
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (ROW)
  • Summary of the Market for Advanced Drug Delivery Systems by Region

Chapter 8 Overview of the Advanced Medical Device Industry

  • Mergers and Acquisitions (M&A)
  • Trends in Clinical Trials on Drug Delivery Systems

Chapter 9 Review of Patents on Advanced Drug Delivery Systems

Chapter 10 Market Summary

  • Overview of the Market for Advanced Drug Delivery Systems
  • Market Drivers and Restraints
  • Market Estimates and Analysis

Chapter 11 Company Profiles

  • ABBOTT LABORATORIES
  • ADARE PHARMACEUTICALS
  • ALCON INC.
  • ALKERMES
  • AMGEN INC.
  • ASTRAZENECA PLC
  • BAUSCH & LOMB
  • BAXTER INTERNATIONAL INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BIOGEN IDEC
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRISTOL-MYERS SQUIBB
  • CAPSUGEL (LONZA)
  • CATALENT
  • CURE PHARMACEUTICAL
  • EISAI CO., LTD.
  • ENZON PHARMACEUTICALS
  • GENENTECH INC (ROCHE)
  • GENEREX BIOTECHNOLOGY CORP.
  • GILEAD SCIENCES INC.
  • GLAXOSMITHKLINE PLC
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • ELI LILLY AND CO.
  • JANSSEN BIOTECH INC.
  • JOHNSON & JOHNSON
  • KEMPHARM INC.
  • MANNKIND CORP.
  • MERCK & CO.
  • MYLAN LABORATORIES INC.
  • NEKTAR THERAPEUTICS
  • NOVARTIS AG
  • NOVAVAX INC.
  • NOVEN PHARMACEUTICALS
  • PFIZER INC.
  • ROCHE HOLDING AG
  • SANOFI SA
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • XEL PHARMACEUTICALS